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Evaluation of Platelet Reactivity in Patients With Valvular
Heart Disease
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Detroit. Michigan
Transmission electron microscopy with a standardized
in vitro method was used to evaluate the degree of blood
platelet reactivity in 72 normal subjects and 72 patients
with valvular heart disease. Among the patients with
abnormal natural heart valves, 51 had either aortic in-
sufficiency or aortic stenosis, and 21 patients showed
either mitral insufficiencyor mitral stenosis. For normal
subjects, the platelet differential counts were dominated
by the dendritic type platelet, and only a few platelets
showed cytoplasmic spreading between adjacent pseu-
dopodia (spread type). A hyperactive response was de-
fined as greater than 20% of the spread type platelet or
more than 93 aggregates per 100single platelets counted,
or both. Only 6 (8%) of the 72 normal subjects showed
Several investigations (1-6) have suggested that the reac-
tivity of blood platelets is abnormally increased in patients
with valvular heart disease. A hyperactive platelet response
could explain some of the pathologic features seen in these
patients, such as the deposition of platelets and the formation
of thrombi on the surface of altered, natural heart valves
(1-4). Enhanced platelet reactivity could also contribute to
some thromboembolic events known to accompany mitral
valve disease (5,6). Altered platelets, if present, could then
contribute to the complications of valvular heart disease, as
well as participate in the development of the disease process
itself. These possibilities suggested that assessing a different
aspect of platelet function would broaden our understanding
of the platelet response in patients with valvular heart disease.
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hyperactive platelets. In contrast, 45 (62%) of the 72
patients with valvular heart disease had hyperactive
platelets (p < 0.01). For patients with abnormal valves,
the mean percent of the spread type platelet was 35%
with a mean value of 105 platelet aggregates. The in-
creased level of platelet reactivity was independent of
both the position of the valve (aortic versus mitral) and
its functional status (insufficient versus stenotic). Dis-
turbed flow and the exposure of subendothelial throm-
bus-producing materials are features associated with ab-
normal heart valves. These factors, which usually occur
in combination, may explain the hyperactive platelet re-
sponse found in these patients.
Methods
Patient data. We evaluated platelets in 72 normal sub-
jects and 72 patients with abnormal heart valves. In the
normal group, 40 were women and 32 were men; they
ranged in age from 20 to 70 years. Among the patients with
valvular heart disease, 27 were women and 45 were men;
they ranged in age from 14 to 81 years. The study was
approved by the Henry Ford Hospital project research and
Human Rights Committee on August 14, 1976. Twenty-
five patients had predominant aortic insufficiency, 26 had
aortic stenosis, 7 had mitral insufficiency and 14 had mitral
stenosis. Only three of the patients had a history of a throm-
boembolic event, and all three were patients with mitral
valve disease and atrial fibrillation. Two patients had epi-
sodes of cerebral ischemia, presumably due to a cerebral
embolism. One patient had a pulmonary embolism. No pa-
tient with valvular heart disease was receiving platelet in-
hibitory drugs when platelet reactivity was studied. Specif-
ically, patients were excluded if they received any of the
following medications within 1 month of the study: aspirin,
heparin, dipyridamole, allopurinol, sulfinpyrazone and
propranolol.
Platelet electron microscopic survey. At the time we
surveyed the reactivity of each platelet population using a
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Figure 1. In vitro platelet response of a normal subject showing
a predominance of the dendritic type platelet (arrow). 5,400X ,
reduced by 42%.
Figure 2. In vitro platelet response of a patient with aortic valve
disease. The spread type platelet (arrows) and large aggregates
dominated the differential count. 4,500X, reduced by 42%.
The level ofplatelet reactivity appeared to be similar for
various ages in our group of patients. We determined a
linear correlation between the platelet hyperactive response
and age and found that the slope of the best fit curve was
not statistically different from zero. Likewise, we found no
significant difference in the level of platelet reactivity be-
tween female and male patients (p > 0.05).
When the degree ofplatelet reactivity was assessed with
respect to the position of the valve, hyperactive platelet
populations were found in 30 (59%) of the 51 patients with
standardized in vitro method (7,8), the number of circulating
platelets/rnm' was also determined. Three distinct types of
platelets were observed when the platelets were classified
at the magnification level of the transmission electron mi-
croscope. The round type was compact, had a smooth con-
tour, was uniformly electron-dense and corresponded to the
disc-shaped circulating platelet. The dendritic type was
characterized by a compact, electron-dense central area from
which pseudopodia extruded. The spread type showed vary-
ing degrees of cytoplasmic spreading between adjacent
pseudopodia in addition to relocation of the internal organ-
elles. A platelet differential count included the percent of
round, dendritic and spread type platelets found on exam-
ination of 100 consecutive single platelets. We also recorded
the number of platelet aggregates counted during the clas-
sification of the 100 single platelets.
Statistical analysis. We compared the percent of the
spread type platelet, the number of platelet aggregates and
the number of circulating platelets in the normal subjects
and patients with valvular heart disease. The same variables
for subgroups of patients relative to age, sex, valve position
(aortic versus mitral) and functional status of the altered
heart valve (insufficiency versus stenosis) were analyzed.
We used the two sample t statistical test to determine sig-
nificance. Results for the percent of the spread type platelet
and number of aggregates are reported as the mean value
± 2 standard deviations.
Results
Normal subjects. The number of circulating platelets in
our normal subjects averaged 288,000/mm3 (range 158,000
to 418,000). The differential platelet counts were consist-
ently dominated by the dendritic type platelet (Fig. 1). The
combined percent of round and dendritic types had a mean
value of 92% (range 70 to 100), whereas the mean percent
of the spread type was 8% (range ° to 20). The aggregating
tendency of platelet populations from normal subjects var-
ied, with an average of 46 platelet aggregates observed per
100 single platelets counted (range 0 to 93). The ranges
reflect ± 2 standard deviations. Hyperactive platelet pop-
ulations (more than 20 of the spread type platelet or more
than 93 platelet aggregates per 100 single platelets counted,
or both) were found in only 6 (8%) of the 72 normal subjects.
Patients with valvular heart disease. The number of
circulating platelets in the patients with valvular heart dis-
ease averaged 283,900/mm3 (range 127,000 to 608,000).
A hyperactive platelet response was defined as greater than
20% of the spread type platelet or more than 93 aggregates
per 100 single platelets counted, or both. In contrast to our
normal series, in which only 8% of the subjects had a hy-
peractive response, 45 (62%) of the 72 patients with valvular
heart disease showed a hyperactive platelet response (prob-
ability [p] < 0.01). The average percent of the spread type
platelet(Fig. 2) was 35, witha meanof 105plateletaggregates.
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an abnormal aortic valve and 15 (71%) of the 21 patient s
with mitral valve disease . The average percents of the spread
type platelet were 37 and 32%, and the mean number of
aggregat es observed was 99 and 119, respectively (Table
I). The mean platelet count was consistently within the
normal range.
If the fun ctional status of the diseased aortic and mitral
valves was considered relevant to whether the valves were
either insufficient or stenotic. the following percents of pa-
tients within the different subgroups showed hyperactive
populat ions of platelets: aortic insufficiency , 60% (15 of
25); aortic stenosis, 58% (15 of 26); mitral insufficiency ,
100% (7 of 7) and mitral stenosis, 57% (8 of 14) (Table
I). The corresponding mean percents for the spread type
platelet were 35, 38, 36 and 30%, and the associated num-
bers of aggregates observed were 10I , 97 , 146 and 106.
No statistically significant differences (p > 0.05) in plate-
let reactivity were found for: I) aortic valvular heart disease
versus mitral valvular heart disease; 2) aortic insufficiency
versus aortic stenosis; 3) mitral insufficiency versus mitral
stenosis; 4) aortic insuffic iency versus mitral insufficiency;
and 5) aortic stenosis versus mitral stenosis.
Discussion
Previous studies. Previous report s (1-4) suggest that an
altered natural heart valve may serve as a localized nidus
for the thrombotic process in vivo. In a previous study (3),
we used scanning electron microscopy to examine the ex-
terior of stenotic aortic valves. We found that endotheli al
cells were both morphologically altered and actually lost
from the surface of these valves so that subendothelial com-
ponents, such as collagen, were available to the circulating
blood. We further observed both single platelets and platelet
aggregates adhering to exposed collagen fibers. Comparable
pathologic findings (9) and Riddle et al. (unpublished data)
have also been reported for the diseased , natural mitral
valve , and recentl y, slices from abnormal mitral valves were
shown to exhibit an increa sed thromboplastic activity com-
bined with a decrea sed fibrinolytic capacity (10).
Alterations in the consumption of platelets (II ) and their
concentration of releasable materials (12) have also been
observed in patient s with valvular heart disease . Platelet
survival in vivo was shortened with mitral valve disea se ,
although it was reportedl y normal in patients with aortic
stenosis (II ). A decreased amount of both adeno sine di-
phosphate (ADP) and adenosine triphosphate (ATP) was
released in vitro when platelet populations from patient s
with valvular heart disease were compared with those of
normal subjects (12). This study implies that these sub-
stances were secreted from the platelets in vivo .
Criteria of platelet reactivity. In our study, we used a
technical approach (7,8) that differed from the usual method
of determining platelet reactivity in patients with valvular
heart disease. Our standardized in vitro test system provided
a morphologic assessment for three variables of the platelet
response: adhesion, surface activation and aggregation. The
presence of numerous platelet s on the surface of the Form var
film reflected their adhes ive capacity. Surface activation was
demonstrated by the extrusion of pseudopodia, cytoplasmic
spreading between pseudopodia and the reorganization of
internal organelle s. Aggregation , indicative of the cohe sive
capacity of each populati on of platelet s, was directl y ob-
served by countin g the number of platelet aggregates seen
during the classification of 100 single platelets. The major
advantage of this method, as opposed to the more comm only
used method of aggregometry , is that one can directl y ob-
serve structural change s when platelets contact an activating
surface (Formvar film) in vitro.
Effect of valvular disease on platelet reactivity. Our
study provide s further evidence that the functional charac-
teristics of platelets from patient s with valvular heart disea se
differ from those of normal subjects. We found that more
than 50% of the patients with valvular heart disease had a
hyperactive platelet response; however, the degree of in-
creased platelet reactivity did not differ significantly be-
tween aortic and mitral valve disease. Platelets were not
only hyperactive as determined by our in vitro survey, but
they also appeared to be more react ive in vivo as shown by
our previous scanning electron microscopic observat ions
Table I. Platelet Reactivity in Patients With Aortic or Mitral Valve Disease
Patients With
Average % of Average No. Platelet
Patients
Hyperact ive Platelets
Spread Type of Platelet Count
Patient Group (no) no . iff Platelets Aggregates per rnnr'
Aortic valve disease
Insufficiency 25 15 60 35 101 313 .000
Stenos is 26 15 58 38 97 248 .000
Total aortic valve disease 51 30 59 37 99 280 .000
Mitral valve disease
Insufficiency 7 7 100 36 146 288.000
Stenos is 14 8 57 30 106 295.000
Total mitral valve disease 21 15 71 32 119 293.000
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(3). In both instances, adherent platelets showed dendritic
processes, cytoplasmic spreading between pseudopodia and
aggregate formation.
Role of turbulent flow. In addition to the interaction
between platelets and exposed subendothelial components,
the deposition of microthrombi on stenotic valves may also
relate to abnormal conditions of flow. Hemodynamic factors
that have been implicated in thrombus formation include
high shear stresses in combination with wall interactions
(13-14), turbulence (15-17) and the added effects of vor-
tices (I8).
When turbulent flow was measured in patients in the
region of stenotic and regurgitant aortic valves, it was pres-
ent even for mild stenosis. The intensity of turbulence was
considerably greater in the jet distal to severely stenotic
valves (19). Bicuspid valves, even though not significantly
stenotic, may not open freely (20), causing narrowing or
irregularity of the orifice which contributes to turbulent flow.
Because shear stresses in turbulent jets are large as a result
of additional Reynolds stresses (21), cells are likely to be
damaged. The effects of shear stresses on platelet function
have been studied (22-27). With various levels of stresses
and different exposure times, either the structure, function
or release of active substances from platelets was observed.
Platelets, leukocytes and erythrocytes may contact the
arterial surface of the aortic valve by: normal backflow,
valvular insufficiency (which may be associated with ste-
nosis) and captured anular eddies. The increased adhesive-
ness of the platelets that we observed in patients with val-
vular heart disease would tend to enhance their deposition
on the valve surface.
Conclusion. Progressive valvular disease results in an
altered valve surface with which circulating peripheral blood
elements including platelets, leukocytes and erythrocytes
interact. Subsequent thrombus formation, thickening, fusion
and calcification of the valve cusps produce disturbed pat-
terns of flow. The hyperactive platelet response observed
in our patients with valvular heart disease, therefore, prob-
ably has more than one causative factor.
We thank Patricia Cornett, PhD, Scientific Publications Editor. for editmg
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